SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-021880
Filing Date
2023-02-14
Accepted
2023-02-14 16:56:42
Documents
1
Group Members
SAMSARA BIOCAPITAL GP, LLCSRINIVAS AKKARAJU, MD, PHD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm236533d2_sc13da.htm SC 13D/A 75287
  Complete submission text file 0001104659-23-021880.txt   76865
Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Filed by) CIK: 0001699737 (see all company filings)

IRS No.: 813958301 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Subject) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91570 | Film No.: 23631047
SIC: 2834 Pharmaceutical Preparations